SCHEMBL28887910

SCHEMBL28887910

O=CC(c1ccc(N2CCCCC2)c(NC(=O)c2cccc(Br)n2)c1)C1CNCCO1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 1/20 0.41
▸ PIM3 Q86V86 1/20 0.41
▸ BACE1 P56817 7/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ MAPK10 P53779 1/20 0.36
▸ IRAK4 Q9NWZ3 3/20 0.36
▸ NTRK3 Q16288 1/20 0.35
▸ NTRK2 Q16620 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28382359 0.95 PIM1 (0.41) PIM1PIM3BACE1ALDH1A1MAPT
SCHEMBL28380087 0.89 PIM1 (0.42) PIM1PIM3BACE1ALDH1A1MAPT
SCHEMBL28382326 0.88 PIM1 (0.40) PIM1PIM3
SCHEMBL28379245 0.83 PIM1 (0.42) PIM1PIM3ALDH1A1MAPTL3MBTL1
SCHEMBL28378694 0.83 CYP1A2 (0.53) ALDH1A1MAPTL3MBTL1MAPK10NPSR1
SCHEMBL28383473 0.82 PIM1 (0.39) PIM1PIM3
SCHEMBL28383372 0.81 IRAK4 (0.41) PIM1PIM3BACE1MAPTIRAK4
SCHEMBL28382809 0.80 PIM1 (0.43) PIM1PIM3BACE1ALDH1A1MAPT
SCHEMBL29033218 0.79 CHEK1 (0.54) IRAK4
SCHEMBL28378607 0.78 CSF1R (0.51) ALDH1A1MAPTL3MBTL1MAPK10NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111032642-B Kinase inhibitors and methods of making and using the same 里格尔药品股份有限公司 2023-07-18 — — CN disclosed
CN-111032642-A Kinase inhibitors and methods of making and using 里格尔药品股份有限公司 2020-04-17 — — CN disclosed
Send feedback